MCM2 expression in serrated polyps demonstrates aberrant cellular proliferation

Area of Science:

• Gastroenterology
• Molecular Biology
• Oncology

Background:

• Colonic epithelial proliferation is normally confined to the lower crypt.
• Understanding alterations in proliferation is key to deciphering disease pathophysiology.
• Serrated polyps (SPs) represent a spectrum of colorectal lesions with potential malignant transformation.

Purpose of the Study:

• To investigate the proliferative compartment of serrated polyps using MCM2.
• To assess changes in proliferation along the serrated polyp spectrum.
• To evaluate the potential field effect in adjacent colonic mucosa.

Main Methods:

• Immunohistochemistry using an anti-MCM2 antibody.
• Analysis of normal colonic tissue, hyperplastic polyps (HPs), sessile serrated adenomas (SSAs), and SSAs with dysplasia.
• Comparison of MCM2 staining patterns across different lesion types and normal mucosa.

Main Results:

• Serrated polyps demonstrated expanded proliferative compartments compared to normal colonic crypts.
• 81.3% of HPs and 100% of SSAs showed full crypt MCM2 staining.
• Aberrant MCM2 staining in adjacent normal mucosa was observed in SSAs with dysplasia and a subset of non-dysplastic SSAs, suggesting a field effect.

Conclusions:

• Serrated polyps exhibit significant alterations in cell proliferation during their progression.
• Hyperplastic polyps and SSAs share a similar highly proliferative profile.
• The observed field effect indicates that micro-environmental changes may drive adenoma development and malignancy risk.